The Biometrics and Research Team at Cantargia focuses on integrating advanced data analysis and bioinformatics to support the development of antibody-based therapies targeting IL1RAP. This team collaborates closely with research scientists to design and analyze clinical trials, ensuring robust data management and interpretation to drive scientific advancements in cancer treatment.